• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转录-聚合酶链反应检测微小残留神经母细胞瘤细胞的临床应用

Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.

作者信息

Kuroda T, Saeki M, Nakano M, Mizutani S

机构信息

Department of Surgery, National Children's Hospital, Tokyo, Japan.

出版信息

J Pediatr Surg. 1997 Jan;32(1):69-72. doi: 10.1016/s0022-3468(97)90097-x.

DOI:10.1016/s0022-3468(97)90097-x
PMID:9021573
Abstract

The highly sensitive method to detect neuroblastoma (NB) cells using reverse transcriptase polymerase chain reaction (RT-PCR) was applied in the practical clinics, and its efficacy was assessed in the present study. Human tyrosine hydroxylase (TH), a rate-limiting enzyme in the catecholamine biosynthesis, was used as the marker for NB cells, and the expression of THmRNA was examined in 13 samples (four peripheral blood and nine bone marrow) harvested from seven patients (four with stage IV, one with stage III, two with stage II) using RT-PCR with our original primers. The positive signals for NB cells were detected in four samples (one peripheral blood and three bone marrow) by the PCR method, but were undetectable by the conventional histological examinations. In the present series, a case that showed a positive signal for NB cells in the peripheral blood showed a remarkably unfavorable clinical course, indicating that the circulating NB cells detected by the PCR method can be a sign of the progressively advanced NB, and may define a new prognostic factor suggesting higher risk. In another case, the PCR detection for the residual NB cells in the bone marrow provided important supporting evidence to determine the necessity of the additional chemotherapy and the suitable timing for bone marrow transplantation. This detection also guaranteed the safety of the bone marrow for transplantation. The PCR method was considered to be very beneficial in the selected cases. However, some problems such as the false-negative results in the negative urinary vanillylmandelic acid secretor were also highlighted in the present study.

摘要

本研究应用逆转录聚合酶链反应(RT-PCR)检测神经母细胞瘤(NB)细胞的高灵敏度方法,并在实际临床中进行了疗效评估。人酪氨酸羟化酶(TH)是儿茶酚胺生物合成中的限速酶,用作NB细胞的标志物,使用我们的原始引物通过RT-PCR检测了从7例患者(4例IV期、1例III期、2例II期)采集的13份样本(4份外周血和9份骨髓)中THmRNA的表达。通过PCR方法在4份样本(1份外周血和3份骨髓)中检测到NB细胞的阳性信号,但常规组织学检查未检测到。在本系列中,1例在外周血中显示NB细胞阳性信号的病例临床病程明显不佳,表明通过PCR方法检测到的循环NB细胞可能是NB进展的标志,可能定义一个提示更高风险的新预后因素。在另一例中,对骨髓中残留NB细胞的PCR检测为确定是否需要额外化疗以及骨髓移植的合适时机提供了重要的支持证据。这种检测还确保了用于移植的骨髓的安全性。PCR方法被认为在选定病例中非常有益。然而,本研究也突出了一些问题,如尿香草扁桃酸分泌阴性者出现假阴性结果。

相似文献

1
Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.逆转录-聚合酶链反应检测微小残留神经母细胞瘤细胞的临床应用
J Pediatr Surg. 1997 Jan;32(1):69-72. doi: 10.1016/s0022-3468(97)90097-x.
2
Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.神经母细胞瘤中骨髓和外周血微小病变的临床意义
J Pediatr Surg. 2000 Oct;35(10):1415-20. doi: 10.1053/jpsu.2000.16403.
3
Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.通过逆转录聚合酶链反应检测酪氨酸羟化酶mRNA,以诊断骨髓和外周血中的神经母细胞瘤细胞。
Cancer. 1995 Jun 1;75(11):2757-61. doi: 10.1002/1097-0142(19950601)75:11<2757::aid-cncr2820751120>3.0.co;2-s.
4
Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma.采用实时逆转录聚合酶链反应检测酪氨酸羟化酶以评估晚期神经母细胞瘤的骨髓受累情况。
Oncol Rep. 2003 Mar-Apr;10(2):357-62.
5
Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.神经母细胞瘤细胞转移至血液和骨髓的检测程序:嗜铬粒蛋白A半巢式逆转录聚合酶链反应与酪氨酸羟化酶巢式逆转录聚合酶链反应及抗GD2免疫细胞学法的盲法比较
Diagn Mol Pathol. 2002 Jun;11(2):98-106. doi: 10.1097/00019606-200206000-00006.
6
Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.临床随访期间神经母细胞瘤细胞的检测:使用传统PCR和实时PCR的先进流式细胞术及酪氨酸羟化酶的逆转录PCR。
Klin Padiatr. 2011 Nov;223(6):326-31. doi: 10.1055/s-0031-1287842. Epub 2011 Nov 17.
7
TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.外周血和骨髓中的TH和DCX信使核糖核酸可预测转移性神经母细胞瘤患者的预后。
J Cancer Res Clin Oncol. 2016 Mar;142(3):573-80. doi: 10.1007/s00432-015-2054-7. Epub 2015 Oct 24.
8
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.通过分子检测骨髓中微小残留病对晚期神经母细胞瘤进行预后预测。
Med Pediatr Oncol. 2001 Jan;36(1):203-4. doi: 10.1002/1096-911X(20010101)36:1<203::AID-MPO1049>3.0.CO;2-T.
9
Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.检测非转移性神经母细胞瘤患者外周血和骨髓中的微小疾病。
J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. doi: 10.1007/s00432-011-0997-x. Epub 2011 Jun 25.
10
Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.评估MYCN表达作为神经母细胞瘤细胞标志物通过逆转录聚合酶链反应检测微小残留病的初步研究。
J Pediatr Hematol Oncol. 2006 Oct;28(10):635-41. doi: 10.1097/01.mph.0000212976.13749.8a.

引用本文的文献

1
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.液体活检在儿科实体瘤中的应用综述
NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z.
2
Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse.促转移和间充质基因表达特征可表征患有骨髓转移和复发的神经母细胞瘤患者的循环肿瘤细胞。
Front Oncol. 2022 Sep 13;12:939460. doi: 10.3389/fonc.2022.939460. eCollection 2022.
3
Opportunities and challenges of circulating biomarkers in neuroblastoma.
神经母细胞瘤循环生物标志物的机遇与挑战。
Open Biol. 2019 May 31;9(5):190056. doi: 10.1098/rsob.190056.
4
Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.酪氨酸羟化酶信使 RNA 转录物在神经母细胞瘤患者外周血诊断中的临床意义。
Cancer Res Treat. 2016 Oct;48(4):1399-1407. doi: 10.4143/crt.2015.481. Epub 2016 Mar 24.
5
Cellular kinetics of neuroblastoma and the role of surgery.神经母细胞瘤的细胞动力学及手术的作用。
Pediatr Surg Int. 2011 Sep;27(9):913-7. doi: 10.1007/s00383-011-2949-6. Epub 2011 Jul 19.
6
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.通过免疫细胞学和定量逆转录聚合酶链反应(QRT-PCR)灵敏检测骨髓、血液和干细胞制剂中微小神经母细胞瘤细胞的共识标准:国际神经母细胞瘤风险组工作组的建议
Br J Cancer. 2009 May 19;100(10):1627-37. doi: 10.1038/sj.bjc.6605029. Epub 2009 Apr 28.
7
Tumor cell dynamics and metastasis in advanced neuroblastoma.晚期神经母细胞瘤中的肿瘤细胞动力学与转移
Pediatr Surg Int. 2005 Nov;21(11):859-63. doi: 10.1007/s00383-005-1503-9.
8
Micrometastases in neuroblastoma: are they clinically important?神经母细胞瘤中的微转移灶:它们在临床上重要吗?
J Clin Pathol. 2004 Jan;57(1):14-20. doi: 10.1136/jcp.57.1.14.
9
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.神经节苷脂GM2/GD2合成酶信使核糖核酸是用于检测骨髓中罕见神经母细胞瘤细胞的一种标志物。
Am J Pathol. 2001 Aug;159(2):493-500. doi: 10.1016/S0002-9440(10)61721-X.
10
Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.使用逆转录聚合酶链反应检测肿瘤细胞的改进方法。
Br J Cancer. 1999 Feb;79(5-6):971-7. doi: 10.1038/sj.bjc.6690155.